West Pharmaceutical Services Inc. (WST) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (36% profit margin, 18% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
West Pharmaceutical Services Inc. (WST) surged +3.23% to $416.67 as options desks priced 60% call premium vs. 40% put protection around the $408 max-pain magnet. High-quality cash engine (36% profit margin, 18% return on capital) with steady institutional support.
Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q3 2026, with sales up 8.7% year on year to $874.5 million. The company’s full-year revenue guidance of $3.42
West Pharmaceutical Services (NYSE:WST) reported third-quarter results that exceeded its expectations, driven by continued demand for high-value product components, including those used in GLP-1 therapies and biologics.
Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $412 to $494.
TD Cowen analyst Brendan Smith maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $420 to $500.
Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target from $440 to $500.
Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the price target from $440 to $480.
Moby summary of West Pharmaceutical Services, Inc.'s Q3 2026 earnings call
S&P 500 unusual volume leaders for October 29, 2026 include ServiceNow, Fortinet, Carvana, Boeing, DoorDash, and West Pharmaceutical, with notable price moves.
S&P 500 top movers for today's US session: Carvana and Textron lead gainers, while ServiceNow and Fortinet post the steepest declines.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on WST today. View full Setup Ledger →
Why WST Stock surged +3.23% Today — RQD Quant Desk Flash. High-quality cash engine (36% profit margin, 18% return on capital) with steady institutional support.